To enhance our understanding of the pharmacological effects of active ingredients on sepsis targets, we analyzed naringin, naringenin, and neohesperidin, and associated them with 6 primary targets including BCL2, CASP3, EGFR, ESR1, FN1, and TP53 (see Table 2). The gene discussed is CASP3; the disease is Sepsis.